{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:09:43Z","timestamp":1768536583380,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T00:00:00Z","timestamp":1385596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T00:00:00Z","timestamp":1385596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1038\/gt.2013.69","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T11:14:53Z","timestamp":1385637293000},"page":"168-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV"],"prefix":"10.1038","volume":"21","author":[{"given":"P S","family":"Montenegro-Miranda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Pichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"ten Bloemendaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Duijst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D R","family":"de Waart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J","family":"Bosma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,28]]},"reference":[{"key":"BFgt201369_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/156652309787909508","volume":"9","author":"PS Miranda","year":"2009","unstructured":"Miranda PS, Bosma PJ . Towards liver-directed gene therapy for Crigler\u2013Najjar syndrome. Curr Gene Ther 2009; 9: 72\u201382.","journal-title":"Curr Gene Ther"},{"key":"BFgt201369_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0168-8278(02)00359-8","volume":"38","author":"PJ Bosma","year":"2003","unstructured":"Bosma PJ . Inherited disorders of bilirubin metabolism. J Hepatol 2003; 38: 107\u2013117.","journal-title":"J Hepatol"},{"key":"BFgt201369_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00431-005-0055-2","volume":"165","author":"KA Strauss","year":"2006","unstructured":"Strauss KA, Robinson DL, Vreman HJ, Puffenberger EG, Hart G, Morton DH . Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler\u2013Najjar disease. Eur J Pediatr 2006; 165: 306\u2013319.","journal-title":"Eur J Pediatr"},{"key":"BFgt201369_CR4","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1056\/NEJM199805143382004","volume":"338","author":"IJ Fox","year":"1998","unstructured":"Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI et al. Treatment of the Crigler\u2013Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998; 338: 1422\u20131426.","journal-title":"N Engl J Med"},{"key":"BFgt201369_CR5","first-page":"119","volume":"99","author":"JC Grieger","year":"2005","unstructured":"Grieger JC, Samulski RJ . Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol 2005; 99: 119\u2013145.","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"BFgt201369_CR6","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM199605023341809","volume":"334","author":"JM Wilson","year":"1996","unstructured":"Wilson JM . Adenoviruses as gene-delivery vehicles. N Engl J Med 1996; 334: 1185\u20131187.","journal-title":"N Engl J Med"},{"key":"BFgt201369_CR7","first-page":"565","volume":"1","author":"S Connelly","year":"1999","unstructured":"Connelly S . Adenoviral vectors for liver-directed gene therapy. Curr Opin Mol Ther 1999; 1: 565\u2013572.","journal-title":"Curr Opin Mol Ther"},{"key":"BFgt201369_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/ng0797-270","volume":"16","author":"RO Snyder","year":"1997","unstructured":"Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 1997; 16: 270\u2013276.","journal-title":"Nat Genet"},{"key":"BFgt201369_CR9","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1073\/pnas.94.4.1426","volume":"94","author":"DD Koeberl","year":"1997","unstructured":"Koeberl DD, Alexander IE, Halbert CL, Russell DW, Miller AD . Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc Natl Acad Sci USA 1997; 94: 1426\u20131431.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201369_CR10","first-page":"381","volume":"3","author":"FK Askari","year":"1996","unstructured":"Askari FK, Hitomi Y, Mao M, Wilson JM . Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler\u2013Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase. Gene Therapy 1996; 3: 381\u2013388.","journal-title":"Gene Therapy"},{"key":"BFgt201369_CR11","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1073\/pnas.0500930102","volume":"102","author":"G Toietta","year":"2005","unstructured":"Toietta G, Mane VP, Norona WS, Finegold MJ, Ng P, McDonagh AF et al. Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci USA 2005; 102: 3930\u20133935.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201369_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1089\/hum.2010.167","volume":"22","author":"D Dimmock","year":"2011","unstructured":"Dimmock D, Brunetti-Pierri N, Palmer DJ, Beaudet AL, Ng P . Correction of hyperbilirubinemia in Gunn rats using clinically relevant low doses of helper-dependent adenoviral vectors. Hum Gene Ther 2011; 22: 483\u2013488.","journal-title":"Hum Gene Ther"},{"key":"BFgt201369_CR13","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/mt.2008.37","volume":"16","author":"AP McCaffrey","year":"2008","unstructured":"McCaffrey AP, Fawcett P, Nakai H, McCaffrey RL, Ehrhardt A, Pham TT et al. The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver. Mol Ther 2008; 16: 931\u2013941.","journal-title":"Mol Ther"},{"key":"BFgt201369_CR14","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","volume":"365","author":"AC Nathwani","year":"2011","unstructured":"Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 2011; 365: 2357\u20132365.","journal-title":"N Engl J Med"},{"key":"BFgt201369_CR15","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.ymthe.2006.01.014","volume":"13","author":"J Seppen","year":"2006","unstructured":"Seppen J, Bakker C, de JB, Kunne C, van den OK, Vandenberghe K et al. Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats. Mol Ther 2006; 13: 1085\u20131092.","journal-title":"Mol Ther"},{"key":"BFgt201369_CR16","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1182\/blood-2005-10-4035","volume":"107","author":"AC Nathwani","year":"2006","unstructured":"Nathwani AC, Gray JT, Ng CY, Zhou J, Spence Y, Waddington SN et al. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 2006; 107: 2653\u20132661.","journal-title":"Blood"},{"key":"BFgt201369_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/sj.gt.3301729","volume":"9","author":"NR Thummala","year":"2002","unstructured":"Thummala NR, Ghosh SS, Lee SW, Reddy B, Davidson A, Horwitz MS et al. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler\u2013Najjar syndrome. Gene Therapy 2002; 9: 981\u2013990.","journal-title":"Gene Therapy"},{"key":"BFgt201369_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.virol.2010.12.054","volume":"412","author":"J Schaack","year":"2011","unstructured":"Schaack J, Bennett ML, Shapiro GS, DeGregori J, McManaman JL, Moorhead JW . Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors. Virology 2011; 412: 28\u201335.","journal-title":"Virology"},{"key":"BFgt201369_CR19","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1089\/hum.2007.085","volume":"18","author":"M Nakai","year":"2007","unstructured":"Nakai M, Komiya K, Murata M, Kimura T, Kanaoka M, Kanegae Y et al. Expression of pIX gene induced by transgene promoter: possible cause of host immune response in first-generation adenoviral vectors. Hum Gene Ther 2007; 18: 925\u2013936.","journal-title":"Hum Gene Ther"},{"key":"BFgt201369_CR20","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","volume":"99","author":"GP Gao","year":"2002","unstructured":"Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM . Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854\u201311859.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201369_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/hum.1998.9.4-497","volume":"9","author":"Q Li","year":"1998","unstructured":"Li Q, Murphree SS, Willer SS, Bolli R, French BA . Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler\u2013Najjar syndrome type 1. Hum Gene Ther 1998; 9: 497\u2013505.","journal-title":"Hum Gene Ther"},{"key":"BFgt201369_CR22","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","volume":"91","author":"Y Yang","year":"1994","unstructured":"Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM . Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407\u20134411.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201369_CR23","first-page":"137","volume":"3","author":"Y Yang","year":"1996","unstructured":"Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM . Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Therapy 1996; 3: 137\u2013144.","journal-title":"Gene Therapy"},{"key":"BFgt201369_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/jgm.516","volume":"6","author":"AR Brooks","year":"2004","unstructured":"Brooks AR, Harkins RN, Wang P, Qian HS, Liu P, Rubanyi GM . Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J Gene Med 2004; 6: 395\u2013404.","journal-title":"J Gene Med"},{"key":"BFgt201369_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1053\/j.gastro.2011.04.002","volume":"141","author":"E Breous","year":"2011","unstructured":"Breous E, Somanathan S, Bell P, Wilson JM . Inflammation promotes the loss of adeno-associated virus-mediated transgene expression in mouse liver. Gastroenterology 2011; 141: 357.","journal-title":"Gastroenterology"},{"key":"BFgt201369_CR26","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1089\/10430349950017455","volume":"10","author":"L Pastore","year":"1999","unstructured":"Pastore L, Morral N, Zhou H, Garcia R, Parks RJ, Kochanek S et al. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors. Hum Gene Ther 1999; 10: 1773\u20131781.","journal-title":"Hum Gene Ther"},{"key":"BFgt201369_CR27","doi-asserted-by":"publisher","first-page":"8732","DOI":"10.1128\/JVI.74.18.8732-8739.2000","volume":"74","author":"RP Haberman","year":"2000","unstructured":"Haberman RP, McCown TJ, Samulski RJ . Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A\/D junction element. J Virol 2000; 74: 8732\u20138739.","journal-title":"J Virol"},{"key":"BFgt201369_CR28","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/sj.gt.3302771","volume":"13","author":"CY Wang","year":"2006","unstructured":"Wang CY, Wang S . Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter. Gene Therapy 2006; 13: 1447\u20131456.","journal-title":"Gene Therapy"},{"key":"BFgt201369_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/hum.1997.8.3-359","volume":"8","author":"KM Johnston","year":"1997","unstructured":"Johnston KM, Jacoby D, Pechan PA, Fraefel C, Borghesani P, Schuback D et al. HSV\/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum Gene Ther 1997; 8: 359\u2013370.","journal-title":"Hum Gene Ther"},{"key":"BFgt201369_CR30","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/S0021-9258(18)53762-5","volume":"268","author":"TR Flotte","year":"1993","unstructured":"Flotte TR, Afione SA, Solow R, Drumm ML, Markakis D, Guggino WB et al. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem 1993; 268: 3781\u20133790.","journal-title":"J Biol Chem"},{"key":"BFgt201369_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/hgtb.2011.104","volume":"23","author":"P Fagone","year":"2012","unstructured":"Fagone P, Wright JF, Nathwani AC, Nienhuis AW, Davidoff AM, Gray JT . Systemic errors in quantitative polymerase chain reaction titration of self-complementary adeno-associated viral vectors and improved alternative methods. Hum Gene Ther Methods 2012; 23: 1\u20137.","journal-title":"Hum Gene Ther Methods"},{"key":"BFgt201369_CR32","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1172\/JCI117604","volume":"94","author":"J Seppen","year":"1994","unstructured":"Seppen J, Bosma PJ, Goldhoorn BG, Bakker CT, Chowdhury JR, Chowdhury NR et al. Discrimination between Crigler\u2013Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest 1994; 94: 2385\u20132391.","journal-title":"J Clin Invest"},{"key":"BFgt201369_CR33","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.bbadis.2012.04.013","volume":"1822","author":"PS Montenegro-Miranda","year":"2012","unstructured":"Montenegro-Miranda PS, Sneitz N, de Waart DR, Ten BL, Duijst S, de Knegt RJ et al. Ezetimibe: a biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia. Biochim Biophys Acta 2012; 1822: 1223\u20131229.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt201369_CR34","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"TC He","year":"1998","unstructured":"He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B . A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509\u20132514.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201369_CR35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.2144\/00285bm08","volume":"28","author":"B Bewig","year":"2000","unstructured":"Bewig B, Schmidt WE . Accelerated titering of adenoviruses. Biotechniques 2000; 28: 870\u2013873.","journal-title":"Biotechniques"},{"key":"BFgt201369_CR36","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/jcm.29.9.1804-1811.1991","volume":"29","author":"R Boom","year":"1991","unstructured":"Boom R, Sol CJ, Heijtink R, Wertheim-van Dillen PM, van der Noordaa J . Rapid purification of hepatitis B virus DNA from serum. J Clin Microbiol 1991; 29: 1804\u20131811.","journal-title":"J Clin Microbiol"},{"key":"BFgt201369_CR37","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/gkp045","volume":"37","author":"JM Ruijter","year":"2009","unstructured":"Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 2009; 37: e45.","journal-title":"Nucleic Acids Res"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201369","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:39:18Z","timestamp":1648553958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,28]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["BFgt201369"],"URL":"https:\/\/doi.org\/10.1038\/gt.2013.69","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,28]]},"assertion":[{"value":"28 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}